BIOTECH BEAR ETF LABD ON THE MOVE ON TRUMP SPECULATION, INITIATE OR ADD $LABD
This post was just published on ZYX Buy Change Alert. LABD is a triple leveraged inverse biotech ETF. In plain English, this is a highly leveraged call on biotechs and pharmaceuticals going down if Trump decides to negotiate drug prices. Due to the leveraged nature of LABD, the risk of loss is
January 23, 2017